Baxter rises after first-quarter profit beat
** Shares of medical device maker Baxter BAX.N rise 4.9% to $17.73 premarket ** BAX posts Q1 adj. profit of 36 cents, compared with analysts' estimates of 31 cents - LSEG-compiled data ** Reports Q1 revenue of $2.7 billion vs estimates of $2.62 billion ** Up to last close, stock down 11.6% YTD (Reporting by Siddhi Mahatole) ((siddhi.mahatole@thomsonreuters.com))
Recent news on Baxter International
See all newsS&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Press Digest: British Business - August 20
Brief: Baxter Appoints John Rogers Chief Financial Officer
Brief: Baxter Announces Pricing For Its Upsized Cash Tender Offers